Quest Diagnostics Reports Strong Third Quarter 2024 Financial Results; Updates Full Year 2024 Guidance

SECAUCUS, N.J., October 22, 2024 – Quest Diagnostics Incorporated (NYSE: DGX), a prominent provider of diagnostic information services, re

This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Quest Diagnostics’s 8K filing here.

About Quest Diagnostics

(Get Free Report)

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services.

Featured Articles